T2 Biosystems Announces First Quarter 2023 Financial Results
May 23, 2023 08:05 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
T2 Biosystems Announces Exploration of Strategic Alternatives and the Implementation of a Restructuring Program
May 23, 2023 08:01 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced it...
T2 Biosystems Announces FDA 510(k) Submission for the T2Biothreat Panel
May 23, 2023 08:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Reschedules First Quarter 2023 Financial Results Reporting to May 23, 2023
May 22, 2023 08:15 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 22, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today it...
T2 Biosystems Reschedules First Quarter 2023 Financial Results Reporting to May 22, 2023
May 17, 2023 16:05 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 17, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that...
T2 Biosystems Postpones Reporting of First Quarter 2023 Financial Results
May 15, 2023 16:05 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 15, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today it...
T2 Biosystems to Report First Quarter 2023 Financial Results on May 15, 2023
May 01, 2023 16:05 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., May 01, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that...
T2 Biosystems Highlights New Clinical Data Presented at the ECCMID 2023 Conference
April 26, 2023 08:30 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today highlighted...
T2 Biosystems Announces Webinar and White Paper Highlighting T2Candida Panel Clinical Data and Best Practices
April 05, 2023 08:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., April 05, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced...
T2 Biosystems Affirms Plans to Add Candida Auris Detection to the FDA-Cleared T2Candida Panel
March 23, 2023 09:00 ET
|
T2 Biosystems, Inc.
LEXINGTON, Mass., March 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today affirmed...